Literature DB >> 30547443

A Drug Repurposing Method Based on Drug-Drug Interaction Networks and Using Energy Model Layouts.

Mihai Udrescu1,2, Lucreţia Udrescu3.   

Abstract

Complex network representations of reported drug-drug interactions foster computational strategies that can infer pharmacological functions which, in turn, create incentives for drug repositioning. Here, we use Gephi (a platform for complex network visualization and analysis) to represent a drug-drug interaction network with drug interaction information from DrugBank 4.1. Both modularity class- and force-directed layout ForceAtlas2 are employed to generate drug clusters which correspond to nine specific drug properties. Most drugs comply with their cluster's dominant property; however, some of them seem not to be in a proper position (i.e., in accordance with their already known functions). Such cases, along with cases of drugs that are topologically placed in the overlapping or bordering zones between clusters, may indicate previously unaccounted pharmacologic functions, thus leading to potential repositionings. Out of the 1141 drugs with relevant information on their interactions in DrugBank 4.1, we confirm the predicted properties for 85% of the drugs. The high prediction rate of our methodology suggests that, at least for some of the 15% drugs that seem to be inconsistent with the predicted property, we can get very good repositioning hints. As such, we present illustrative examples of recovered well-known repositionings, as well as recently confirmed pharmacological properties.

Keywords:  Bioinformatics; Clustering; Complex networks; Drug-drug interactions; Pharmacology; Systems biology

Mesh:

Year:  2019        PMID: 30547443     DOI: 10.1007/978-1-4939-8955-3_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Uncovering New Drug Properties in Target-Based Drug-Drug Similarity Networks.

Authors:  Lucreţia Udrescu; Paul Bogdan; Aimée Chiş; Ioan Ovidiu Sîrbu; Alexandru Topîrceanu; Renata-Maria Văruţ; Mihai Udrescu
Journal:  Pharmaceutics       Date:  2020-09-16       Impact factor: 6.321

2.  In Silico Screening of Synthetic and Natural Compounds to Inhibit the Binding Capacity of Heavy Metal Compounds against EGFR Protein of Lung Cancer.

Authors:  Zainab Ayaz; Bibi Zainab; Umer Rashid; Noura M Darwish; Mansour K Gatasheh; Arshad Mehmood Abbasi
Journal:  Biomed Res Int       Date:  2022-05-14       Impact factor: 3.246

Review 3.  On the road to explainable AI in drug-drug interactions prediction: A systematic review.

Authors:  Thanh Hoa Vo; Ngan Thi Kim Nguyen; Quang Hien Kha; Nguyen Quoc Khanh Le
Journal:  Comput Struct Biotechnol J       Date:  2022-04-19       Impact factor: 6.155

4.  Network-based piecewise linear regression for QSAR modelling.

Authors:  Jonathan Cardoso-Silva; Lazaros G Papageorgiou; Sophia Tsoka
Journal:  J Comput Aided Mol Des       Date:  2019-10-18       Impact factor: 3.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.